Stuttgart - Delayed Quote EUR

Northwest Biotherapeutics, Inc. (NBYB.SG)

Compare
0.2800
+0.0180
+(6.87%)
As of 7:15:30 PM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
27,865.0000
31,323.0000
40,160.0000
32,899.0000
Total Liabilities Net Minority Interest
93,638.0000
159,426.0000
164,151.0000
395,847.0000
Total Equity Gross Minority Interest
-65,773.0000
-128,103.0000
-123,991.0000
-362,948.0000
Total Capitalization
-45,461.0000
-122,112.0000
-98,835.0000
-354,441.0000
Common Stock Equity
-65,773.0000
-128,103.0000
-123,991.0000
-362,948.0000
Capital Lease Obligations
4,768.0000
4,724.0000
5,543.0000
5,083.0000
Net Tangible Assets
-67,691.0000
-130,021.0000
-125,909.0000
-364,866.0000
Working Capital
-41,079.0000
-116,580.0000
-116,479.0000
-366,913.0000
Invested Capital
-24,981.0000
-106,574.0000
-91,596.0000
-348,174.0000
Tangible Book Value
-67,691.0000
-130,021.0000
-125,909.0000
-364,866.0000
Total Debt
45,560.0000
26,253.0000
37,938.0000
19,857.0000
Net Debt
38,666.0000
14,564.0000
17,226.0000
4,791.0000
Share Issued
1,175,459.0000
1,068,400.0000
948,400.0000
829,600.0000
Ordinary Shares Number
1,175,459.0000
1,068,400.0000
948,400.0000
829,600.0000
12/31/2020 - 1/29/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers